The biopharmaceutical sector continued to rise in the afternoon, with FUSHILAI hitting the daily limit
The biopharmaceutical sector continued to rise in the afternoon, with FUSHILAI, Xizang Weixinkang Pharmaceutical, and Well Pharmaceutical hitting the daily limit, while Salubris, Hengrui Pharma, and Dongcheng Biochem had the largest gains